← Open Payments lookup

SUSAN ALBERT: Open Payments

NPI 1982287017 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,218 in 83 payments from 19 companies in 2025. Trend: 2023 $593 · 2024 $1,292 · 2025 $1,218

Food & beverage: $1,218
CompanyPaymentsAmount
Novo Nordisk Inc21$301
ABBVIE INC.19$255
GlaxoSmithKline, LLC.11$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$76
Electromed, Inc.5$72
PFIZER INC.4$70
Vanda Pharmaceuticals Inc.3$49
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$47
Neurocrine BioSciences, Inc.2$37
AstraZeneca Pharmaceuticals LP2$29

Products named: VRAYLAR, TRELEGY ELLIPTA, Wegovy, CAPLYTA, SMARTVEST, Ozempic, FANAPT, XIFAXAN.

Industry payments across PA — which companies pay providers there.